Table I.
DNA fragments used in this study
| Size (bp) | % GC | Optimala CpG |
Non- optimalb CpG |
M.SssI site (cg) |
Alu I site (agct) |
|
|---|---|---|---|---|---|---|
| CG50 | 607 | 52.0 | 50 | 0 | 50 | 0 |
| CGSubOp | 727 | 52.8 | 0 | 27 | 27 | 6 |
| CGneg | 629 | 42.4 | 0 | 0 | 0 | - |
| pCpG-mcs | 3070 | 38.9 | 0 | 0 | 0 | - |
| CpG island Clone-11 |
573 | 58.6 | 2 | 42 | 44 | - |
| CpG island Clone-12 |
453 | 52.5 | 0 | 19 | 19 | - |
| CpG island Clone-14 |
597 | 49.6 | 1 | 38 | 39 | - |
| CpG island Clone-15 |
587 | 56.7 | 3 | 34 | 37 | - |
| CpG island Clone-23 |
574 | 52.6 | 0 | 40 | 40 | - |
| SUMO | 618 | 33.0 | 0 | 1 | 1 | - |
a
Optimal CpG: purine-purine-unmethylated cytosine–guanine-pyrimidine-pyrimidine
b
Non-optimal CpG: unmethylated cytosine–guanine, with flanking bases different from optimal CpG motif.